E Gilles

LDH correlation with survival in advanced melanoma from two large, randomised trials (Oblimersen GM301 and EORTC 18951)

Sanjiv S. Agarwala, Ulrich Keilholz, E Gilles et al. · European Journal of Cancer · 2009 · 137 citations

Medicine, Biomedical Sciences, Oncology +13

Phase I study of onapristone, a type I antiprogestin, in female patients with previously treated recurrent or metastatic progesterone receptor-expressing cancers

Paul Cottu, Jacques Bonneterre, Andréa Varga et al. · PLoS ONE · 2018 · 28 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Burkitt's lymphoma in adults: a retrospective study of 46 cases.

M Ostronoff, Carole Soussain, E Zambon et al. · PubMed · 1992 · 27 citations

Medicine, Hematology, Oncology +14

EZN-2968, a novel hypoxia-inducible factor-1α (HIF-1α) messenger ribonucleic acid (mRNA) antagonist: Results of a phase I, pharmacokinetic (PK), dose-escalation study of daily administration in patients (pts) with advanced malignancies

A. Patnaik, E. Gabriela Chiorean, Anthony Tolcher et al. · Journal of Clinical Oncology · 2009 · 27 citations

Medicine, Oncology, Pharmacology +12

Trabectedin in third line breast cancer: A multicenter, randomized, phase II study comparing two administration regimens

Jayne Gurtler, Laura H. Goldstein, Stefano Delprete et al. · Journal of Clinical Oncology · 2005 · 26 citations

Medicine, Oncology, Pharmacology +14